PBM
Psyence Biomedical Ltd. Common Shares
NASDAQ: PBM · HEALTHCARE · BIOTECHNOLOGY
$2.98
-5.70% today
Updated 2026-07-29
Market cap
$11.02M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-12.85
Dividend yield
—
52W range
$2 – $75
Volume
0.1M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C7.3
Quality
B+3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
10.5
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Altman Z 10.54 — safe zone
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-8.64M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $8.01M | $-51.16M | $1.01M | $-6.94M | $-6.94M |
| EPS | — | — | — | — | $-12.85 |
| Free cash flow | $-2153.00 | $-2.95M | $-3.74M | $-8.64M | $-8.64M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Psyence Biomedical Ltd. Common Shares trades at $2.98. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 10.54, it sits in the safe zone.
Frequently asked questions
What is Psyence Biomedical Ltd. Common Shares's stock price?
Psyence Biomedical Ltd. Common Shares (PBM) trades at $2.98.
Is Psyence Biomedical Ltd. Common Shares overvalued?
Psyence Biomedical Ltd. Common Shares carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
Altman Z-Score?
Psyence Biomedical Ltd. Common Shares's Altman Z-Score is 10.54, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-74.30%
Beta1.68
50D MA$3.87
200D MA$35.58
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—